Skip to content
10-Q

Quarterly Report

GUIDED THERAPEUTICS INC GTHP

0001477932-26-003195

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 96.54M sh
Shares Diluted Q1 2026 · Mar 31, 2026 88.84M sh
Shares Diluted Q1 2026 · Mar 31, 2025 68.29M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$617K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$331K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$5.18M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$6.01M
Stockholders Equity restated Q1 2026 · Mar 31, 2025 −$5.03M
Stockholders Equity restated Q1 2026 · Dec 31, 2024 −$4.89M
Current Liabilities Q1 2026 · Mar 31, 2026 $5.96M
Current Liabilities Q1 2026 · Dec 31, 2025 $6.64M
Total Liabilities Q1 2026 · Mar 31, 2026 $6.78M
Total Liabilities Q1 2026 · Dec 31, 2025 $7.33M
Current Assets Q1 2026 · Mar 31, 2026 $911K
Current Assets Q1 2026 · Dec 31, 2025 $605K
Total Assets Q1 2026 · Mar 31, 2026 $1.6M
Total Assets Q1 2026 · Dec 31, 2025 $1.32M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.01
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.01
Eps Basic Q1 2026 · Mar 31, 2026 −$0.01
Eps Basic Q1 2026 · Mar 31, 2025 −$0.01
Sga Expense Q1 2026 · Mar 31, 2026 $451K
Sga Expense Q1 2026 · Mar 31, 2025 $267K
Rd Expense Q1 2026 · Mar 31, 2026 $45K
Rd Expense Q1 2026 · Mar 31, 2025 $74K
Net Income Q1 2026 · Mar 31, 2026 −$500K
Net Income restated Q1 2026 · Mar 31, 2025 −$427K
Operating Income Q1 2026 · Mar 31, 2026 −$302K
Operating Income Q1 2026 · Mar 31, 2025 −$414K
Gross Profit Q1 2026 · Mar 31, 2026 $0
Gross Profit Q1 2026 · Mar 31, 2025 $0
Revenue Q1 2026 · Mar 31, 2026 $0
Revenue Q1 2026 · Mar 31, 2025 $0